STOCK TITAN

Kiromic BioPharma Inc - KRBP STOCK NEWS

Welcome to our dedicated news page for Kiromic BioPharma (Ticker: KRBP), a resource for investors and traders seeking the latest updates and insights on Kiromic BioPharma.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Kiromic BioPharma's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Kiromic BioPharma's position in the market.

Rhea-AI Summary
KRBP common stock suspended from trading on Nasdaq, to be quoted on OTC Pink Sheets starting September 14, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.01%
Tags
clinical trial
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
28.24%
Tags
clinical trial
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.27%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
44.12%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.9%
Tags
management
Kiromic BioPharma Inc

Nasdaq:KRBP

KRBP Rankings

KRBP Stock Data

3.57M
1.01M
12.24%
0.28%
3.89%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
US
Houston

About KRBP

kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. our cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times.